We are live on ! Find out more
Adage Capital Partners

Adage Capital Partners Portfolio holdings

AUM $64.8B
1-Year Est. Return 42.7%
This Fund
S&P 500
This Quarter Est. Return
-12.58%
1 Year Est. Return
+42.7%
3 Year Est. Return
+139.29%
5 Year Est. Return
+204.38%
10 Year Est. Return
+829.83%
AUM
$43.6B
AUM Growth
-$9.03B
Cap. Flow
-$1.48B
Cap. Flow %
-3.4%
Top 10 Hldgs %
21.41%
Holding
1,190
New
110
Increased
278
Reduced
409
Closed
115

Top Sells

Rank Stock Value
1
RPRX icon
Royalty Pharma
RPRX
+$333M
2
XOM icon
ExxonMobil
XOM
+$242M
3
DLTR icon
Dollar Tree
DLTR
+$231M
4
NTR icon
Nutrien
NTR
+$213M
5
EYE icon
National Vision
EYE
+$198M

Sector Composition

Rank Sector Weight
1 Technology 22.53%
2 Healthcare 17.73%
3 Financials 14.85%
4 Consumer Discretionary 9.35%
5 Industrials 8.07%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
GRDI
651
DELISTED
GRIID Infrastructure Inc. Common Stock
GRDI
$10.8M 0.02%
1,100,000
-100,000
-8% -$986K
CLDX icon
652
Celldex Therapeutics
CLDX
$3.07B
$10.8M 0.02%
400,000
-400,000
-50% -$11.6M
BLEU
653
DELISTED
bleuacacia ltd Class A Ordinary Shares
BLEU
$10.7M 0.02%
1,100,000
MGM icon
654
MGM Resorts International
MGM
$11.7B
$10.7M 0.02%
368,300
-25,000
-6% -$897K
WRK
655
DELISTED
WestRock Company
WRK
$10.6M 0.02%
265,389
-9,500
-3% -$447K
LUMN icon
656
Lumen
LUMN
$6.91B
$10.6M 0.02%
968,282
+6,000
+0.6% +$67.3K
TER icon
657
Teradyne
TER
$63.1B
$10.5M 0.02%
116,824
-102,600
-47% -$10.7M
SVRA icon
658
Savara
SVRA
$1.11B
$10.4M 0.02%
6,864,551
MIDD icon
659
Middleby
MIDD
$6.27B
$10.4M 0.02%
83,221
+24,921
+43% +$3.6M
OTIC
660
DELISTED
Otonomy, Inc.
OTIC
$10.4M 0.02%
5,000,000
NBIX icon
661
Neurocrine Biosciences
NBIX
$16.9B
$10.2M 0.02%
105,000
+20,000
+24% +$1.85M
NBP
662
NovaBridge Biosciences American Depositary Shares
NBP
$191M
$10.2M 0.02%
900,000
-500,000
-36% -$5.99M
OMEG
663
DELISTED
Omega Alpha SPAC Class A Ordinary Shares
OMEG
$10.2M 0.02%
1,030,770
DAVA icon
664
Endava
DAVA
$163M
$10.2M 0.02%
115,000
-10,000
-8% -$1.05M
FRSG
665
DELISTED
First Reserve Sustainable Growth Corp. Class A Common Stock
FRSG
$10.1M 0.02%
1,033,333
VTRS icon
666
Viatris
VTRS
$20.6B
$10.1M 0.02%
963,536
-300
-0% -$3.29K
PARA
667
DELISTED
Paramount Global Class B
PARA
$10.1M 0.02%
408,585
-225,000
-36% -$6.86M
MKTX icon
668
MarketAxess Holdings
MKTX
$5.71B
$10.1M 0.02%
39,350
-400
-1% -$109K
AFAC
669
DELISTED
Arena Fortify Acquisition Corp. Class A Common Stock
AFAC
$9.99M 0.02%
1,000,000
STEP icon
670
StepStone Group
STEP
$4B
$9.95M 0.02%
382,336
+75,608
+25% +$2.06M
SGII
671
DELISTED
Seaport Global Acquisition II Corp. Class A Common Stock
SGII
$9.95M 0.02%
1,000,000
RRAC
672
DELISTED
Rigel Resource Acquisition Corp.
RRAC
$9.94M 0.02%
1,000,000
NFNT
673
DELISTED
Infinite Acquisition Corp.
NFNT
$9.88M 0.02%
1,000,000
FVT
674
DELISTED
Fortress Value Acquisition Corp. III
FVT
$9.83M 0.02%
1,000,000
ARYD
675
DELISTED
ARYA Sciences Acquisition Corp IV Class A Odinary Shares
ARYD
$9.81M 0.02%
1,000,000

Similar funds

Adage Capital Partners's Q2 2022 Portfolio in Review

As of Q2 2022, Adage Capital Partners held 1,190 positions worth $43.6B, down 17% from $52.7B the previous quarter. Its ten largest holdings account for 21% of the portfolio.

Adage Capital Partners withdrew a net $1.48B in Q2 2022, closing 115 positions and reducing 409 holdings. Its most notable exit was Nutrien, an estimated $213M position sold in full.

By sector, the portfolio is most concentrated in Technology at 23% of assets, down from 23% a quarter earlier, followed by Healthcare and Financials.

Against the trend, Adage Capital Partners opened a new position in Booz Allen Hamilton worth $75.6M.

  • Adage Capital Partners's largest Q2 2022 buy was Booz Allen Hamilton: 837,064 shares worth $75.6M.
  • Adage Capital Partners added most to Biohaven Pharmaceutical Holding Company Ltd. in Q2 2022, an estimated $364M increase.
  • Adage Capital Partners's biggest Q2 2022 reduction was Royalty Pharma, cutting an estimated $333M.
  • Adage Capital Partners fully exited Nutrien in Q2 2022, selling an estimated $213M.
  • Adage Capital Partners's ten largest holdings make up 21% of its $43.6B portfolio in Q2 2022.
  • Adage Capital Partners opened 110 new positions and closed 115 in Q2 2022.
  • Adage Capital Partners's portfolio value fell 17% quarter-over-quarter to $43.6B.

Based on Adage Capital Partners's 13F filing for Q2 2022, filed 15 Aug 2022.